Molecular Bases of Endometriosis : The Integration Between Research and Clinical Practice

What are the objectives of the genetic study of individuals? There is great interest from the medical community and also much concern from the lay press about the potential benefits and harms of genetic screening, gene therapy, and even the possibility of cloning individuals. The current use of gene...

Full description

Saved in:
Bibliographic Details
Other Authors: Aparecida Gonçalves, Giovana (Editor)
Format: Book Chapter
Published: IntechOpen 2019
Subjects:
Online Access:Get Fullteks
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02942naaaa2200301uu 4500
001 doab_20_500_12854_66995
005 20210420
020 |a intechopen.79037 
020 |a 9781789851359 
020 |a 9781789846072 
020 |a 9781789851366 
024 7 |a 10.5772/intechopen.79037  |c doi 
041 0 |a English 
042 |a dc 
072 7 |a MJX  |2 bicssc 
100 1 |a Aparecida Gonçalves, Giovana  |4 edt 
700 1 |a Aparecida Gonçalves, Giovana  |4 oth 
245 1 0 |a Molecular Bases of Endometriosis : The Integration Between Research and Clinical Practice 
260 |b IntechOpen  |c 2019 
300 |a 1 electronic resource (86 p.) 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a What are the objectives of the genetic study of individuals? There is great interest from the medical community and also much concern from the lay press about the potential benefits and harms of genetic screening, gene therapy, and even the possibility of cloning individuals. The current use of genetic tests for the detection and treatment of endometriosis is still at an early stage but very important. The determination of susceptibility markers will be increasingly explored in clinical studies and their uses will be much more defined. Still, it seems increasingly likely that major changes will occur over the next decade in how we evaluate and treat our patients. In particular, surgeons and clinicians will have the opportunity to use a number of new tests to predict the future appearance of endometriosis in patients still free of the disease. They may have the power to explore the best therapeutic modality for a particular patient according to his/her genetic makeup. And they will be able to more specifically target prevention measures for family members of people already affected by the disease. It should be understood that molecular diagnosis, especially in asymptomatic individuals, does not mean disease but an increased risk of developing a disease. Ethical implications exist and should not be underestimated. Patients should be advised about the likely implications of such tests, not only after but especially before the achievement of these. A major step has already been overcome and we currently have the basic tools for a new leap in understanding human pathologies responsible for much of the world's mortality. Bridging the great barrier that still separates this basic knowledge and clinical practice is quite a significant challenge. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/3.0/  |2 cc  |4 https://creativecommons.org/licenses/by/3.0/ 
546 |a English 
650 7 |a Geriatric medicine  |2 bicssc 
653 |a Geriatric medicine 
856 4 0 |a www.oapen.org  |u https://mts.intechopen.com/storage/books/8584/authors_book/authors_book.pdf  |7 0  |z Get Fullteks 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/66995  |7 0  |z DOAB: description of the publication